Description

BSE has revised price bands for 21 equity scrips under surveillance, effective May 4, 2026. Bands range from 2% to 20% depending on the scrip.

Summary

BSE’s Department of Surveillance (DOSS) has revised price bands for 21 equity scrips, effective May 4, 2026. The revised bands range from 2% to 20%, replacing the existing levels for each scrip. This is a routine surveillance action aimed at curbing excessive volatility or speculative activity in select securities.

Key Points

  • Price bands revised for 21 scrips across equity segment, effective May 4, 2026.
  • Revised bands: 2% (2 scrips), 5% (12 scrips), 10% (2 scrips), 20% (5 scrips).
  • Action taken by BSE Surveillance department (DOSS).
  • Members may seek clarification at bse.surv@bseindia.com.

Revised Price Bands

Sr. No.Scrip CodeScrip NameRevised Band (%)
1534733Aerpace Industries Ltd5
2544220Clinitech Laboratory Ltd20
3531460Continental Controls Ltd5
4533167Coromandel Engineering Company Ltd5
5531676Emrock Corporation Ltd2
6526717HCP Plastene Bulkpack Ltd5
7504746Indian Link Chain Manufacturers Ltd5
8524622iStreet Network Ltd2
9539542Lux Industries Ltd5
10544635Luxury Time Ltd5
11544750Om Power Transmission Ltd20
12521246Paras Petrofils Ltd5
13530589Prima Plastics Ltd20
14539669RGF Capital Markets Ltd5
15533202Satchmo Holdings Ltd10
16539895Spice Lounge Food Works Ltd5
17532890Take Solutions Ltd5
18531628Tejassvi Aaharam Ltd5
19526139Transgene Biotek Ltd20
20543754Transvoy Logistics India Ltd10
21543974Vishnu Prakash R Punglia Ltd5

Regulatory Changes

Price bands are revised by BSE Surveillance as a measure to control abnormal price movements. A tightened band (e.g., 2% or 5%) restricts daily price movement, while a wider band (e.g., 20%) allows greater fluctuation. These revisions supersede previously applicable bands for the listed scrips.

Compliance Requirements

Trading members must note and apply the revised price bands for the affected scrips starting May 4, 2026. No action is required beyond awareness; the exchange systems will enforce the new limits automatically. Members with queries may contact bse.surv@bseindia.com.

Important Dates

  • Notice Date: April 30, 2026
  • Effective Date: May 4, 2026

Impact Assessment

Traders and investors holding positions in any of the 21 affected scrips should be aware of the new daily price movement limits. Scrips assigned a 2% band (Emrock Corporation, iStreet Network) face the most restrictive limits, potentially reducing liquidity. The 5 scrips assigned a 20% band (Clinitech Laboratory, Om Power Transmission, Prima Plastics, Transgene Biotek, and Clinitech Laboratory) have relatively wider movement permitted. Overall market impact is limited to these specific securities; broader indices are unaffected.

Impact Justification

Routine surveillance-driven price band revision affecting 21 specific scrips; material for traders holding these securities but limited broader market impact.